August 30, 2024

   

14:00-15:00 CST

Biostatistics in the Development and Evaluation of Advanced Therapies in China

This webinar features a panel of industry experts discussing key statistical models and analysis within the therapy development market in China.

  • Overview of Statistical Methods in Innovative Drug Development
  • Statistical Analysis of Advanced Therapies for Rare Diseases and Case Studies
  • Considerations of Innovative Statistical Methods in FDA Review

"Integrating Biostatistics in Advanced Therapy Development: Key Insights and Applications for China" 

Panelists

Dr. David Ng

Dr. David Ng  

Vice President of Biometrics & Data Management, Novotech 

Dr. Yafei Zhang

Dr. Yafei Zhang  

Director of Biostatistics, Novotech   
 

Dr. Shan Xiao

Dr. Shan Xiao

Associate Director of Biostatistics, Takeda Pharmaceuticals